In a multicenter case-control trial, this form of estrogen replacement, unlike oral estrogen, was not associated with an increased risk of VTE.
Medscape Medical News
Laurie Barclay
Source: http://www.medscape.com/viewarticle/459782?rss
[Editor: The preceding article was not written by A4M/WHN]